Skip to content

Effectiveness of ultrashort wave therapy in patients with chronic rhino sinusitis with nasal polyps: protocol for a randomized controlled trial

Effectiveness of ultrashort wave therapy in patients with chronic rhino sinusitis with nasal polyps

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092411
Enrollment
Unknown
Registered
2024-11-15
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhino sinusitis with nasal polyps

Interventions

Control group:Conventional medicine + blank USW diathermy therapy (machine will not on)
USW group:Conventional medicine + USW diathermy therapy (machine will on)

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria 1) Subjects diagnosed with CRSwNP; 2) >=18 years old; 3) CRS with bilateral NP; 4) Endoscopic bilateral nasal polyp score of at least 1 (out of 8) for each nasal cavity; 5) Symptoms lasting at least 8 weeks prior to study entry, including: moderate or severe symptoms (2 or 3 points), nasal congestion, or nasal congestion, and a weekly mean severity score of at least 1 point (range 0 to 3 points) at randomization; 6) At least one other symptom, such as partial loss of smell (hyposmia), complete loss of smell (anosmia), or anterior or posterior rhinorrhea; 7) Patients with concomitant asthma must have been stable with conventional asthma treatment for the previous 6 weeks.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1) Previous USW treatment; 2) Had sinus surgery (including removal of nasal polyps) within 6 months prior to visit; 3) Patients with forced expiratory volume in the first second (FEV1)<=50% of the expected normal value (co-asthmatic patients); 4) Postnasal sinus polyps were present; 5) Acute sinusitis; 6)Upper respiratory tract infection; 7) Cystic fibrosis; 8) Mycotic rhinosinusitis; 9) Yang Syndrome; 10) Kartagener syndrome or ciliary immotility syndrome.

Design outcomes

Primary

MeasureTime frame
Nasal polyp score under bilateral nasal endoscopy;

Secondary

MeasureTime frame
Nasal congestion or obstruction score;SNOT-22 total score;Smell test (UPSIT) score;Loss-of-smell score;Lund-Mackay CT total score;Rhino sinusitis disease severity;Baseline peak nasal inspiratory flow;Baseline blood eosinophils;

Countries

China

Contacts

Public ContactHe Chengqi

West China Hospital, Sichuan University

hxkfhcq2015@126.com+86 189 8060 1618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026